Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gold and silver: Breakout time, not bubble time

The Chinese ideograph for crisis is represented by the sign for danger joined together with the symbol for opportunity. Admittedly, for over a year and a half precious metals investors have been going through a time for testing of our essential position in wealth in...

The Later United States Empire

In 1917, the United States created the federal debt limit (or ceiling) to make it easier to finance World War One, essentially allowing Congress to borrow money to pay for the war effort by issuing bonds. By 1939 with World War Two looming, Congress passed the first aggre...

Canadian mining, oil & gas have a lot to lose from minority government

In mid-August, a ground-breaking ceremony of sorts took place in Edmonton for the Trans Mountain Pipeline project . Natural Resources Minister Amarjeet Sohi picked the yard of pipeline contractor SA Energy to announce that Trans Mountain Corp. is moving forward to constr...

Golden Arrow Resources Sells 25% Interest in Puna Operations to SSR Mining for $44.4M

The Critical Investor looks beyond the headlines to analyze the factors behind the company's sale of its JV share to its partner. Puna Operation, Chinchillas Mine Golden Arrow Resources Corp. (GRG:TSX.V; GARWF:OTCQB; G6A:FSE) surprised the ...

Negative Rates, Access to Deal Flow and a First Time Ever for Doug Casey

Doug is a legend in the business. Like with most legends, comes the peanut gallery that try to bash what he has accomplished to have their dorky voices heard among the roar of a legend. Ask yourself this, these trolls who bash, what have they accomplished? Doug has ...

GBP/USD – Pound in Holding Pattern Ahead of British GDP, Manufacturing Production

Kenny Fisher GBP/USD is showing little movement for a fifth straight day. Currently, the pair is trading at 1.3155, up 0.07% on the day. All Eyes on British GDP, Mfg. Production Investors are keeping a close eye on the monthly GDP report....

GBP/USD – Pound Gaining Ground as Boris Holds Lead in Polls

It’s Election Day across the U.K, and millions of voters will determine what happens next with the Brexit saga, which has lasted three years. If Prime Minister Johnson can win an outright majority, the British pound could respond with significant gains. ...

Target Raised on Explorer; Val d'Or Project Is 'Gift That Keeps on Giving

The latest drill results are delivered and interpreted in an iA Securities report. In an Aug. 1 research note, analyst George Topping reported that iA Securities raised its target price on Wesdome Gold Mines Ltd. (WDO:TSX) to CA$7.50 per share from CA$7 bec...

Target Price Raised on 'One of the Highest-Quality Stories' in Oil & Gas

The changes made and the reasons for them are detailed in a Raymond James report. In an Oct. 8 research note, analyst Justin Jenkins reported that Raymond James raised its target price on Phillips 66 (PSX:NYSE) to $120 per share from $117 "on higher conviction in ea...

Aquestive Therapeutics Shares Up on Pipeline Update and Raised Full-Year 2019 Guidance

Aquestive Therapeutics shares traded 20% higher today after the firm reported Q3/19 earnings and raised its FY/19 guidance. The firm states it expects to complete its NDA for Libervant buccal film near the end of this month. Yesterday afternoon, specialty pharmaceutic...
1 2 3 4 5 6 7 8 9 10 ...